Journal of Rheumatic Diseases

Download original image
Fig. 2. The changes of the skin lesions. The initial appearance of the skin lesion at her second visit for worsening in December 2020 (A) and after a biopsy, she had prescribed rivaroxaban for superficial thrombo-occlusive vascular disease. In 2 weeks, the skin lesion which being treated with rivaroxaban (B), and in 3 months, she had complete resolution of symptoms (C).
J Rheum Dis 2022;29:187~189 https://doi.org/10.4078/jrd.2022.29.3.187
© J Rheum Dis